Skip to main content

Table 1 Baseline characteristics of subjects that completed the intervention

From: The effects of an innovative GP-physiotherapist partnership in improving COPD management in primary care

 

TOTAL

n = 31

Mean age, years (SD)

75 (9.3)

Gender (female)

19 (61%)

Mean body mass index, Kg/m2 (SD)

27.7 (5.3)

Born in Australia

20 (65%)

English spoken at home

140 (97%)

Identify as Aboriginal and/or Torres Strait Islander

2 (7%)

Currently married or de facto

16 (52%)

Employment status

 

 Employed-full/part-time/casual

4 (13%)

 Retired/pensioner

25 (81%)

 Unemployed/student/disability pension/home duties/carer

2 (6%)

Education

 Some primary school

1 (3%)

 Completed high school/some high school

12 (39%)

 Tertiary education/vocational training

18 (58%)

Smoking status

 Current

5 (16%)

 Former

24 (77%)

 Never smoked

2 (7%)

Mean number of co-morbidities (SD)

5 (3.1)

Mean post-bronchodilator FEV1/FVC (SD)

0.61 (0.1)

Mean post-bronchodilator FEV1% predicted (SD)

75 (18.6)

GOLD Stage I

18 (58%)

GOLD Stage II

2 (6%)

GOLD Stage III

0 (0%)

GOLD Stage IV

1 (1%)

  1. Data are presented as Number (%) unless indicated otherwise
  2. Abbreviations: COPD Chronic Obstructive Pulmonary Disease, FEV1 Forced expiratory volume in one second, FVC Forced vital capacity, GOLD Global Initiative for Chronic Obstructive Lung Disease, SD standard deviation
  3. COPD GOLD staging classification2—Stage 1: FEV1 ≥ 80%; Stage 2: FEV1 50–79%; Stage 3: FEV1 30–49%; Stage 4: FEV1 < 30%